Comparative evaluation of Allplex RV master assay and biofire respiratory panel 2.1 plus for detection of respiratory viruses
Abstract
Respiratory tract infections are among the most prevalent diseases worldwide, causing significant morbidity and mortality, particularly in children, the elderly, and immunocompromised individuals. Early and accurate diagnosis is essential to reduce their health burden. Diagnostic methods include culture, serology, and rapid antigen tests; however, nucleic acid amplification assays, particularly multiplex PCR, are considered the gold standard due to their high sensitivity and specificity. This study aimed to compare the diagnostic performance of open-PCR multiplex platform Allplex RV Master Assay for the detection of respiratory viruses using a cartridge-based syndromic platform BioFire Respiratory Panel 2.1 plus (RP2.1plus) as a comparator. A cross-sectional study was conducted on 65 positive nasopharyngeal swabs, which were analyzed using both systems. Positive percent agreement ranged from 75 to 100%, negative percent agreement from 92.59 to 100%, and kappa values from 0.48 to 1.00. The good concordance between the two assays supports the use of Allplex Respiratory Panel 1 as a reliable alternative for rapid and accurate diagnosis of viral respiratory infections.
Related
- Comparative evaluation of metagenomic and targeted next-generation sequencing for pathogen detection in bronchoalveolar lavage fluid from patients with lower respiratory tract infections: a retrospective cohort study.
- Clinical impact of the BIOFIRE FILMARRAY Pneumonia Panel combined with antimicrobial stewardship education on pediatric patients with lower respiratory tract infection: a pre–post study from a tertiary center in Nara, Japan
- Evaluation of the One-Step Multiplex Real-Time Reverse Transcription-PCR ProFlu-1 Assay for Detection of Influenza A and Influenza B Viruses and Respiratory Syncytial Viruses in Children
- Real-life evaluation of BioFire® BCID2 and Vitek® REVEALTM for Gram-negative bloodstream infections in critical care
- Evaluation of whole genome sequencing protocols and target-capture panels for detection of respiratory viruses in clinical specimens
BibTeX
@article{abdelhamid2026comparative,
title = {{Comparative evaluation of Allplex RV master assay and biofire respiratory panel 2.1 plus for detection of respiratory viruses}},
author = {Sara Mohammad Abdel-Hamid and Ghada Abdel-Wahed Ismail and Nashwa Naguib Omar and Basma Sherif and Samar Saad Rashad},
journal = {Scientific Reports},
year = {2026},
month = oct,
doi = {10.1038/s41598-026-73014-8},
url = {https://www.nature.com/articles/s41598-026-73014-8},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Comparative evaluation of Allplex RV master assay and biofire respiratory panel 2.1 plus for detection of respiratory viruses
AU - Sara Mohammad Abdel-Hamid
AU - Ghada Abdel-Wahed Ismail
AU - Nashwa Naguib Omar
AU - Basma Sherif
AU - Samar Saad Rashad
PY - 2026
DA - 2026/10/20
JO - Scientific Reports
DO - 10.1038/s41598-026-73014-8
UR - https://www.nature.com/articles/s41598-026-73014-8
AB - Respiratory tract infections are among the most prevalent diseases worldwide, causing significant morbidity and mortality, particularly in children, the elderly, and immunocompromised individuals. Early and accurate diagnosis is essential to reduce their health burden. Diagnostic methods include culture, serology, and rapid antigen tests; however, nucleic acid amplification assays, particularly multiplex PCR, are considered the gold standard due to their high sensitivity and specificity. This study aimed to compare the diagnostic performance of open-PCR multiplex platform Allplex RV Master Assay for the detection of respiratory viruses using a cartridge-based syndromic platform BioFire Respiratory Panel 2.1 plus (RP2.1plus) as a comparator. A cross-sectional study was conducted on 65 positive nasopharyngeal swabs, which were analyzed using both systems. Positive percent agreement ranged from 75 to 100%, negative percent agreement from 92.59 to 100%, and kappa values from 0.48 to 1.00. The good concordance between the two assays supports the use of Allplex Respiratory Panel 1 as a reliable alternative for rapid and accurate diagnosis of viral respiratory infections.
SN - 2045-2322
ER -